Basket

Record was added to the basket

1.Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases

Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases / Matúšková, M. ... [et al.] . Journal of experimental & clinical cancer research : CR . - Vol. 34, no. 1 (2015), s. 33 [Dokument nie je vo fonde knižnice]
From the basket
Citation
Bookmark

Selected documents
Citation

citace PRO
article

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.